Gainers
-
SELLAS Life Sciences Group, Inc. (NYSE: SLS) shares
surged 150.72 percent to close at $8.65 on Monday after the company disclosed positive interim data from its Phase 2b NeuVax
trial.
-
Seven Stars Cloud Group, Inc. (NASDAQ: SSC) shares
rose 22.07 percent to close at $2.60. Seven Stars Cloud Group on Friday reported FY17 loss of $0.16 per share on revenue of
$144.34 million.
-
BioLife Solutions, Inc. (NASDAQ: BLFS) shares
surged 20.47 percent to close at $6.18 after the company reported preliminary revenue for the three months ended March 31,
2018.
-
MediciNova, Inc. (NASDAQ: MNOV) shares gained
18.88 percent to close at $12.15.
-
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT)
gained 18.7 percent to close at $32.50.
-
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA)
shares rose 18.6 percent to close at $13.07.
-
Red Violet, Inc. (NASDAQ: RDVT) surged 13.93
percent to close at $6.95.
-
Avid Bioservices, Inc. (NASDAQ: CDMO) shares
jumped 13.7 percent to close at $3.32.
-
NACCO Industries, Inc. (NYSE: NC) shares gained 11.11
percent to close at $36.50 on Monday.
-
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose
10.9 percent to close at $2.55.
-
Commvault Systems, Inc. (NASDAQ: CVLT) jumped
10.84 percent to close at $63.40 after Elliott Management disclosed a 10.3 percent stake in Commvault and announced intent to
nominate 4 candidates to the board.
-
ArQule, Inc. (NASDAQ: ARQL) shares rose 10.4
percent to close at $3.18.
-
Resonant Inc. (NASDAQ: RESN) shares jumped 10.03
percent to close at $3.51 as the company reported settlement of proxy contest with Park City Capital.
-
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) rose
5.86 percent to close at $10.84. Barclays initiated coverage on BioXcel Therapeutics with an Overweight rating.
-
Humana Inc. (NYSE: HUM) rose 4.42 percent to close
at $280.70. Walmart is reportedly in early stage acquisition talks with Humana.
Losers
-
SORL Auto Parts, Inc. (NASDAQ: SORL) fell 23.35
percent to close at $4.99 after the company reported downbeat earnings for its fourth quarter..
-
Alkermes plc (NASDAQ: ALKS) dipped 21.96 percent
to close at $45.23 on Monday after the U.S. Food and Drug Administration said it won't review the company's therapy ALKS-5461.
Alkermes, which mostly focuses on treatments for central nervous system diseases, said in a press release it received a Refusal
to File letter from the FDA regarding its New Drug Application (NDA) for ALKS-5461.
-
China Auto Logistics Inc. (NASDAQ: CALI) shares
dropped 19.13 percent to close at $2.79 on Monday after rising 1.17 percent on Thursday.
-
SYNNEX Corporation (NYSE: SNX) shares declined 18.24
percent to close at $96.80. SYNNEX posted upbeat earnings for its first quarter, but issued weak earnings outlook for the
current quarter.
-
Veritiv Corporation (NYSE: VRTV) shares tumbled
18.24 percent to close at $32.05.
-
LSC Communications, Inc. (NYSE: LKSD) shares fell
18.17 percent to close at $14.28. Bank of America downgraded LSC Communications from Neutral to Underperform.
-
IZEA, Inc. (NASDAQ: IZEA) dropped 18.03 percent
to close at $3.00 as the company disclosed that it will reschedule its Q4 earnings release.
-
Allied Healthcare Products, Inc. (NASDAQ: AHPI)
fell 17.54 percent to close at $2.35.
-
Comstock Resources, Inc. (NYSE: CRK) dropped 17.1
percent to close at $6.06. Comstock Resources reported a $75 million stock investment from Jerry Jones.
-
Longfin Corp. (NASDAQ: LFIN) shares dropped 17.09
percent to close at $14.31 after declining 48.80 percent on Thursday.
-
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) fell
15.05 percent to close at $101.18.
-
RXi Pharmaceuticals Corporation (NASDAQ: RXII)
dropped 14.6 percent to close at $2.75.
-
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM)
shares dipped 14.47 percent to close at $17.02. Rhythem Pharma will pay $5 million of stock for the rights to develop and
commercialize a treatment from Takeda Pharma.
-
Cymabay Therapeutics, Inc. (NASDAQ: CBAY) shares
tumbled 14.24 percent to close at $11.14.
-
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)
dropped 14.15 percent to close at $19.66.
-
KemPharm, Inc. (NASDAQ: KMPH) shares fell 13.92
percent to close at $6.80. KemPharm posted a Q4 loss of $0.72 per share.
-
Galectin Therapeutics, Inc. (NASDAQ: GALT) shares
fell 13.08 percent to close at $4.12.
-
Ovid Therapeutics Inc. (NASDAQ: OVID) shares fell
12.87 percent to close at $6.16.
-
Long Blockchain Corp. (NASDAQ: LBCC) fell 12.78
percent to close at $2.32. Long Blockchain shares gained over 7 percent in after-hours trading after a 13D filing from Stater
Blockchain showed a 8.5 percent stake in the company.
-
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)
shares declined 11.72 percent to close at $27.50.
-
Pfenex Inc. (NASDAQ: PFNX) shares declined 11.67
percent to close at $5.30.
-
Fitbit, Inc. (NYSE: FIT) shares declined 9.41
percent to close at $4.62. Morgan Stanley downgraded Fitbit from Equal-weight to Underweight.
-
Snap Inc. (NYSE: SNAP) dropped 8.88 percent to
close at $14.46 after slipping 0.50 percent on Thursday.
-
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
fell 7.9 percent to close at $19.375 after gaining 2.33 percent on Thursday.
-
Vishay Precision Group, Inc. (NYSE: VPG) shares fell
7.7 percent to close at $28.75.
-
ICICI Bank Limited (NYSE: IBN) fell 7.46 percent to
close at $8.19 following probe reports by Indian Police.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.